who should not take glp-1 nausea: How to handle GLP-1s' most common side effect Why do patients stop GLP-1

Metabol-Clin Exp (1999) 48:3859

These data are in agreement with non-controlled clinical studies reporting that 72 h of native GLP-1 infusion improved regional and global left ventricular performance in patients with acute myocardial infarction and severe systolic dysfunction [619]

The biggest update is that several Indian pharmaceutical companies have already launched semaglutide products after patent expiry

Aroda, B.S

A very-low-fat, whole-food plant-based diet addresses the actual driver of insulin resistance: intracellular fat that blocks insulin from doing its job

Although use of GLP-1RAs does not increase the risk of severe hypoglycaemia, 10 it may elevate the risk of hypoglycaemia caused by insulin and sulfonylureas if prescribed with these agents